Novo-Nordisk A/S
NVO
$41.55
per share, on-chain
What Novo-Nordisk A/S does
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Industry
- Healthcare
- CEO
- Maziar Mike Doustdar
- Website
- novonordisk.com
Ways to own Novo-Nordisk A/S
There's one version of this stock on Firstshare.
OndoNVOonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$41.55
Open, outside US hours
Price check
What a slice looks like
$10.00 buys you 0.24 of one Novo-Nordisk A/S share.
That's 24.1% of one share. Small, but it's yours, and it moves with the real price. One share costs $41.55.